| Rolling adhesion | | |
| Jurkat cells rolling on VCAM-1 at 2 dyn/cm2 shear stress. After channels were coated with ligand and blocked, Jurkat cells were introduced and images were captured at 10 frames/sec. Average rolling velocity can be calculated using the BioFlux Software Image Stacker Module. | |
| | | |
| Firm adhesion | | |
 | Calcein AM stained Jurkat cells adhering to VCAM-1 after treatment with anti-VLA4 antibodies. In contrast to screening bulk fluorescence to quantitate adhesion, unusual phenomena such as cell clumping due to antibody-induced homotypic fusion (top of image) can be characterized by microscopy and morphometry. | |
| | | |
| Pharmacological interactions / drug screening | |
 | High-throughput compound screens for drug dose response can be performed under physiological conditions in the BioFlux system, with multiple replicates. Shown here are the results of a IC50 screen of Jurkat cells treated with three inhibitors of adhesion to VCAM-1, similar to those used to treat MS. | |